IDEXX Laboratories Inc.

United States of America Country flag United States of America
Sector: Medical Supplies
Ticker: IDXX
Factsheet Factsheet

Market multiple valuation of IDEXX Laboratories Inc. ( IDXX | USA)

The most common multiple used in the valuation of stocks is the P/Earnings NTM multiple (Price to Earnings). P/E relates the current share price with the market expectations in terms of Earnings Per Share. This multiple is used to compare a company's market value with its earnings. A company with a high P/Earnings NTM is considered to be overvalued; a company with a low P/Earnings NTM is considered to be undervalued.
The P/Earnings NTM ratio of IDEXX Laboratories Inc. is significantly higher than the median of its peer group: around 24.00. The company valuation of IDEXX Laboratories Inc. according to these metrics is way above the market valuation of its peer group.
The P/Earnings NTM ratio of IDEXX Laboratories Inc. is significantly higher than the average of its sector (Medical Supplies): 16.27. The company valuation of IDEXX Laboratories Inc. according to these metrics is way above the market valuation of its sector.
The P/Earnings NTM ratio of IDEXX Laboratories Inc. is lower than its historical 5-year average: 52.7. The (current) company valuation of IDEXX Laboratories Inc. is therefore below its valuation average over the last five years.

Valuation
P/E Last P/E (e) 2021P/E NTM
IDEXX Laboratories Inc.Free trialFree trialFree trial
International PeersFree trialFree trialFree trial
Medical Supplies12.9518.6716.27
NASDAQ 10025.7424.0521.50
United States of America0.779.439.28
More...
Beta (Ref: NASDAQ 100)
Levered betaUnlevered beta
1-Year1.081.06
2-Year1.071.05
3-Year1.121.10
More...
Stock Perf excl. Dividends (in USD)
IDXXNASDAQ 100Rel. Perf.
Year-to-Date-34.9%-28.7%-6.2%
1-Week-2.4%-3.4%0.9%
1-Month11.9%5.2%6.7%
1-Year-30.7%-29.0%-1.7%
3-Year70.5%38.6%31.9%
5-Year166.9%83.4%83.5%
More...
International Peers - IDEXX Laboratories Inc.
Company NameCtryMarket
Cap.
last (mUSD)
IDEXX Laboratories Inc.USA35 567
International Peers Median1.07
Abbott LaboratoriesUSA186 423
Thermo Fisher Scientifi...USA222 748
Charles River Laborator...USA10 684
Bio-Rad Laboratories In...USA12 593
Lepu Medical Technology...CHN6 197
GPRV Analysis
IDEXX Laboratories I...
Intl. Peers
U.S Patents No. 7,882,001 & 8,082,201
More...
Net Sales Chart
More...
Quotes Chart

1-Year Rebased Stock Chart

  • IDEXX Laboratories Inc.
  • NASDAQ 100
More...

Did you know ?

On the Infront Analytics platform, there are two ways to identify the listed peers which most closely resemble a private firm:
- with Peer Tracker if you already know a listed peer.
Peer Tracker is a patented technology tool for building peer groups using industry classifications. The degree of similarity between two companies is calculated comparing their sector footprints and measured using comparability scores.
- with Market Screener if you have no listed peer in mind.
Market Screener is a dedicated interface for screening companies using multiple criteria, identifying peers, searching for comparable companies in a specific business sector.

About Market Multiples

Many methods can be used to value a company. In reality, business valuation is often a combination of these different approaches. One of the most widely used quantitative methods is the market multiples method. The market valuation is utilized generally as a primary market input, to provide an objective starting point for the valuation. Put simply, this method multiplies the sales or profits of a business by an industry averaged multiplier to calculate the Market Value of the business.
Current multiples include:
- Historical multiples based on standardized financials for the last completed fiscal period: Last, Last Twelve Months (LTM);
- Forward multiples based on consensus estimates for the current fiscal period and next ones: Next Twelve Months (NTM), FY0, FY1.
Current multiples based on per-share metrics (such as earnings per share or book value per share) are calculated using the last closing price, while current multiples based on company-level metrics (such as net sales, EBIT or EBITDA) are calculated using the current market cap or EV (Enterprise Value).